Global Quantum Biotechnology Market
Market Size in USD Billion
CAGR :
%

![]() |
2025 –2032 |
![]() |
USD 321.00 Million |
![]() |
USD 930.56 Million |
![]() |
|
![]() |
Global Quantum Biotechnology Market Segmentation, By Application (Drug Discovery and Development, Genomics and Proteomics, Bioinformatics, Diagnostics, Therapeutics, Agricultural Biotechnology, and Environmental Biotechnology), Technology (Quantum Computing, Quantum Sensing, Quantum Cryptography, and Quantum Imaging), End-Use (Pharmaceuticals and Healthcare, Agriculture, Environmental, and Energy), Component (Hardware, Software, and Services) – Industry Trends and Forecast to 2032
Quantum Biotechnology Market Analysis
The Quantum Biotechnology market is experiencing rapid growth, driven by the increasing application of quantum computing, sensing, and imaging technologies in life sciences. Quantum advancements are revolutionizing drug discovery, genomics, diagnostics, and bioinformatics, offering solutions to complex problems that traditional methods struggle to address. Drug development, particularly through faster molecular simulations and precise genetic analysis, benefits from quantum algorithms, reducing time and cost in research and clinical trials. In bioinformatics, quantum computing significantly enhances data processing power, enabling more accurate genomic sequencing and personalized medicine.
Key industries, including pharmaceuticals, agriculture, and healthcare, are leading the adoption of quantum biotechnology. Pharmaceuticals are leveraging quantum technologies to design novel therapies, while agriculture benefits from quantum-based genetic modification and crop optimization. In the healthcare sector, quantum diagnostics and imaging techniques are improving precision medicine and early disease detection.
Despite its promising potential, the market faces challenges such as high costs and the need for specialized talent and infrastructure. However, ongoing advancements in quantum technology, coupled with growing investments from both private and public sectors, are expected to accelerate innovation. The market is expected to expand rapidly as quantum biotechnology applications continue to demonstrate their value in addressing critical challenges in the life sciences and healthcare industries.
Quantum Biotechnology Market Size
The global quantum biotechnology market size was valued at USD 321 million in 2024 and is projected to reach USD 930.56 million by 2032, with a CAGR of 14.23% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Quantum Biotechnology Market Trends
“Growing Demand for Quantum Technologies”
The Quantum Biotechnology market is experiencing significant growth, due to the growing demand for quantum technologies to address complex challenges in biology and healthcare. Quantum computing is at the forefront, providing unparalleled computational power that accelerates drug discovery, genomics research, and protein folding simulations. This speed and accuracy drive the development of new therapies, reduce costs, and improve precision in medical treatments. In bioinformatics, quantum algorithms are transforming data processing, enabling more effective personalized medicine and advanced disease prevention.
Quantum sensing and imaging are also playing a key role in transforming diagnostics, offering more sensitive and precise biological measurements that allow for earlier disease detection. Furthermore, quantum innovations are making a significant impact in agriculture, enhancing genetic optimization for improved crop yields and disease resistance.
The market's rapid growth is supported by increasing investments from both private and public sectors. As quantum technologies continue to advance, their ability to solve intricate problems in life sciences propels the ongoing expansion of the Quantum Biotechnology market.
Report Scope and Quantum Biotechnology Market Segmentation
Attributes |
Quantum Biotechnology Key Market Insights |
Segments Covered |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Italy, Spain, Denmark, Sweden, Norway, Rest of Europe in Europe, China, Japan, India, South Korea, Australia, Thailand, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Kuwait, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Key Market Players |
Accenture (Ireland), Alibaba Cloud (China), Alphabet Inc. (U.S.), Atos SE (France), British Telecommunications plc (UK), D-Wave Quantum Inc. (Canada), Fujitsu (U.S.), Honeywell International Inc (U.S.), IBM (U.S.), Intel Corporation (U.S.), IonQ, Inc. (U.S.), Microsoft (U.S.), PsiQuantum (U.S.), Quantinuum (U.S.), QC Ware (U.S.), Rigetti & Co, LLC. (U.S.), Robert Bosch GmbH (Germany), SAP SE (Germany), SAMSUNG (South Korea) and Xanadu (Canada) |
Market Opportunities |
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. |
Quantum Biotechnology Market Definition
Quantum Biotechnology is an interdisciplinary field that integrates principles of quantum mechanics with biotechnology to develop innovative solutions for biological and healthcare applications. It leverages quantum technologies, such as quantum computing, quantum sensing, and quantum imaging, to enhance various processes in biotechnology, including drug discovery, genomics, diagnostics, bioinformatics, and agricultural biotechnology. By utilizing the unique properties of quantum systems, such as superposition and entanglement, quantum biotechnology enables faster data processing, more accurate simulations, improved diagnostics, and more effective disease treatments.
Quantum Biotechnology Market Dynamics
Drivers
- Advancements in Quantum Computing for Drug Discovery and Genomics
A major driver of the Quantum Biotechnology market is the ability of quantum computing to accelerate drug discovery and genomics. Quantum computers can simulate molecular structures and their interactions far more efficiently than classical computers, allowing researchers to explore drug candidates quickly and accurately. For instance, companies such as IBM and Google are already using quantum algorithms to model protein folding and predict molecular behaviors, which can reduce the lengthy and costly process of drug development. In genomics, quantum computing can speed up DNA sequencing and analysis, enabling more precise treatments tailored to individual genetic profiles. Quantum-enabled innovations, such as improved drug testing models, can significantly reduce time-to-market for new drugs. As more industries explore these capabilities, the market will see heightened demand for quantum computing in biotechnology, driving advancements in personalized medicine and accelerated therapeutic development, thereby supporting the growth of market.
- Quantum Sensing and Imaging for Enhanced Diagnostics
Quantum sensing and imaging technologies are revolutionizing the diagnostic field, offering unprecedented sensitivity and resolution. These tools can detect biological markers at the molecular level, enabling early diagnosis of diseases that are otherwise difficult to identify in their early stages. For instance, quantum-enhanced imaging can improve magnetic resonance imaging (MRI) and other imaging techniques, offering higher resolution scans with more precise insights into cellular structures and disease progression. Companies such as D-Wave and Qnami are developing quantum sensors that can be used in medical diagnostics to detect anomalies with high accuracy. Quantum-based diagnostic devices are poised to replace conventional methods, improving both the speed and accuracy of disease detection, especially in conditions such as cancer. This growing ability to provide non-invasive, precise diagnostics at the molecular level will drive the adoption of quantum biotechnology in healthcare systems globally, propelling the market's growth.
Opportunities
- Personalized Medicine and Targeted Therapies
One significant opportunity in the quantum biotechnology market is the development of personalized medicine and targeted therapies. Quantum computing can process complex genomic data much faster than classical computing, enabling the creation of treatments tailored to an individual’s genetic profile. This opens up new possibilities in treating diseases such as cancer, where quantum-based simulations can help identify specific genetic mutations and predict how a patient’s body will respond to various drugs. For instance, pharmaceutical companies such as Roche and Pfizer are exploring quantum algorithms to refine drug discovery processes and personalize treatments. By accelerating the identification of the most effective drugs for each patient, quantum biotechnology can enhance the success rate of treatments and reduce adverse effects. As a result, personalized medicine is emerging as a major opportunity for quantum biotechnology, with the potential to revolutionize healthcare on a global scale thus opening up new growth avenues for the market globally.
- Quantum-Enhanced Agricultural Biotechnology
Another emerging opportunity for the quantum biotechnology market lies in agricultural biotechnology. Quantum technologies, such as quantum sensors and imaging, can significantly improve the efficiency of agricultural practices by enhancing crop optimization and genetic engineering. Quantum computing can be used to model plant genomes and predict how crops will respond to environmental changes, leading to the development of more resilient and high-yield crops. For instance, companies such as Google’s DeepMind are already applying AI-powered quantum models to better understand complex biological systems, which could later be applied to agricultural optimization. Quantum sensing also holds promise in monitoring soil quality, pest control, and water usage, leading to more sustainable farming practices. The integration of quantum biotechnology in agriculture presents opportunities to address food security challenges, increase sustainability, and reduce the environmental impact of farming, thus supporting the growth of the market.
Restraints/Challenges
- High Cost and Infrastructure Requirements
One major restraint in the Quantum Biotechnology market is the high cost of quantum technology and the significant infrastructure required for its implementation. Quantum computing systems, for instance, demand specialized hardware and cooling systems, which are expensive to develop and maintain. This high upfront cost limits the accessibility of quantum biotechnology tools to well-funded organizations and large enterprises, leaving smaller companies and startups at a disadvantage. For instance, building quantum computers requires sophisticated technology such as cryogenic cooling to maintain quantum states, which adds substantial operational costs. This financial barrier may slow the widespread adoption of quantum technologies across the biotechnology sector, limiting its potential.
- Complexity and Expertise Gaps
A significant challenge in the Quantum Biotechnology market is the complexity of quantum technologies and the shortage of qualified experts to implement and operate them. Quantum systems require specialized knowledge in both quantum mechanics and biotechnology, making it difficult for professionals in the biotechnology sector to adopt these technologies without extensive training. For instance, quantum computing specialists are needed to design algorithms, while biotechnologists must understand how to integrate these algorithms into biological research. This expertise gap presents a challenge to the successful application of quantum technologies in biotechnology, as there is a limited pool of talent in this interdisciplinary field.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Quantum Biotechnology Market Scope
The market is segmented on the basis of application, technology, end-use, and component. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Application
- Drug Discovery and Development
- Genomics and Proteomics
- Bioinformatics
- Diagnostics
- Therapeutics
- Agricultural Biotechnology
- Environmental Biotechnology
Technology
- Quantum Computing
- Quantum Sensing
- Quantum Cryptography
- Quantum Imaging
End-Use
- Pharmaceuticals and Healthcare
- Agriculture
- Environmental
- Energy
Component
- Hardware
- Software
- Services
Quantum Biotechnology Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, of application, technology, end-use, and component as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Italy, Spain, Denmark, Sweden, Norway, Rest of Europe in Europe, China, Japan, India, South Korea, Australia, Thailand, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Kuwait, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the Quantum Biotechnology market. This region, particularly the United States, is a leader in both quantum computing and biotechnology research, with significant investments from both the private sector and government entities. Major technology companies such as IBM, Google, and Microsoft, which are pioneering quantum computing innovations, have strong partnerships with universities and research institutes to advance quantum biotechnology applications. Furthermore, the U.S. government has made substantial investments in quantum technologies through initiatives such as the National Quantum Initiative Act, which aims to accelerate the development of quantum computing and its application across various industries, including healthcare and biotechnology.
Asia-Pacific is expected to exhibit the highest growth rate in the Quantum Biotechnology market. This region is witnessing rapid advancements in quantum technology and biotechnology, fueled by significant investments from both governments and private sectors. Countries such as China, Japan, and India are making substantial strides in both fields. China, for instance, has become a global leader in quantum research and is heavily investing in quantum computing, with the government outlining strategic plans for quantum technology development in its national agenda. Japan and South Korea are also enhancing their capabilities in quantum computing and biotechnology, with companies and research institutions collaborating to drive innovations.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Quantum Biotechnology Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Quantum Biotechnology Market Leaders Operating in the Market Are:
- Accenture (Ireland)
- Alibaba Cloud (China)
- Alphabet Inc. (U.S.)
- Atos SE (France),
- British Telecommunications plc (UK)
- D-Wave Quantum Inc. (Canada)
- Fujitsu (U.S.)
- Honeywell International Inc (U.S.)
- IBM (U.S.)
- Intel Corporation (U.S.)
- IonQ, Inc. (U.S.)
- Microsoft (U.S.)
- PsiQuantum (U.S.)
- Quantinuum (U.S.)
- QC Ware (U.S.)
- Rigetti & Co, LLC. (U.S.)
- Robert Bosch GmbH (Germany)
- SAP SE (Germany)
- SAMSUNG (South Korea)
- Xanadu (Canada)
Latest Developments in Quantum Biotechnology Market
- In January 2025, IonQ announced a 21.1 million USD project in partnership with Qubitekk, Inc. to collaborate with the United States Air Force Research Lab (AFRL). This initiative marks another major milestone for IonQ as it works with AFRL to establish quantum network infrastructure at the Innovare Advancement Center in Rome, New York. The project will support AFRL’s Quantum Information Science & Technology Branch at the Information Directorate, advancing its research in quantum networking and computing.
- In September 2024, PsiQuantum announced plans to expand its operations in Queensland, Australia, by opening a 'Test & Characterization' lab at Griffith University's Nathan Campus in Brisbane. The lab space at Griffith’s Nathan Campus will undergo renovations, with PsiQuantum anticipating a move into the new facility in early 2025.
- In February 2024, Xanadu received a repayable contribution from the Government of Canada, through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), to support companies in advancing and commercializing their quantum products. This funding, provided through the Regional Quantum Initiative (RQI), will help accelerate the development of PennyLane, Xanadu's open-source, cloud-based software framework for quantum machine learning, quantum chemistry, and quantum computing.
- In January 2024, Accenture announced a strategic investment through Accenture Ventures in QuantHealth, an AI-driven company that specializes in cloud-based clinical trial simulations. This investment aims to help pharmaceutical and biotech companies accelerate and reduce the costs of developing treatments for patients. QuantHealth’s clinical trial simulation platform has the potential to expedite clinical trials, enabling pharmaceutical and biotech companies to deliver life-saving treatments to patients more quickly.
- In October 2023, Samsung Semiconductor India Research (SSIR) announced a collaboration with the Indian Institute of Science (IISc) to establish a state-of-the-art Quantum Technology Lab. This initiative aligns with SSIR's CSR commitment and is designed to offer research and training opportunities for numerous faculty members and hundreds of students pursuing higher education, both at IISc and other academic institutions.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.